| RS1064793941 |
C2CD3
|
Health Risk |
Pathogenic |
— |
| RS1064793942 |
RNASEH2C
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 3, Aicardi-Goutieres syndrome 3 |
| RS1064793943 |
FAT4
|
Health Risk |
Likely pathogenic |
— |
| RS1064793944 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1064793945 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1064793946 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1064793947 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1064793948 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS1064793951 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064793952 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1064793955 |
KAT6A
|
Health Risk |
Pathogenic |
— |
| RS1064793956 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1064793957 |
ATM
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1064793958 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793959 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS1064793962 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1064793964 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS1064793967 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064793969 |
APC
|
Health Risk |
Pathogenic |
— |
| RS1064793972 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1064793974 |
WAS
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS1064793975 |
KDM5C
|
Health Risk |
Pathogenic |
— |
| RS1064793976 |
SPAST
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1064793977 |
KRT5
|
Health Risk |
Pathogenic |
— |
| RS1064793978 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1064793979 |
FERMT1
|
Health Risk |
Pathogenic |
Kindler syndrome, Kindler syndrome |
| RS1064793980 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064793981 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064793983 |
DSG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy |
| RS1064793984 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS1064793985 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1064793986 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1064793987 |
ADAR
|
Health Risk |
Pathogenic |
— |
| RS1064793988 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS1064793989 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1064793990 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS1064793991 |
PTCH1
|
Health Risk |
Pathogenic |
— |
| RS1064793992 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1064793994 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1064793995 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793996 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1064793998 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Monogenic diabetes |
| RS1064793999 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064794000 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1064794001 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1064794003 |
TMEM67
|
Health Risk |
Pathogenic |
— |
| RS1064794004 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064794005 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, SCN2A-related generalized epilepsy with febrile seizures plus |
| RS1064794006 |
DYRK1A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1064794007 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1064794009 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS1064794010 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064794012 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Hearing loss |
| RS1064794013 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1064794014 |
DNAH11
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS1064794016 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064794017 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ovarian cancer |
| RS1064794018 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1064794019 |
CERT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 34 |
| RS1064794020 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1064794021 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1064794022 |
CNKSR2
|
Health Risk |
Pathogenic |
— |
| RS1064794023 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064794024 |
SMARCA2
|
Health Risk |
Pathogenic |
— |
| RS1064794025 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064794026 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1064794027 |
IL2RG
|
Health Risk |
Likely pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS1064794028 |
MSH6
|
Health Risk |
Pathogenic |
— |
| RS1064794029 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1064794030 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS1064794031 |
BMPR1A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1064794033 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1064794034 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064794035 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS1064794036 |
CPAP
|
Health Risk |
Likely pathogenic |
— |
| RS1064794037 |
VHL
|
Health Risk |
Pathogenic |
— |
| RS1064794038 |
KANSL1
|
Health Risk |
Pathogenic |
— |
| RS1064794039 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064794040 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1064794042 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1064794043 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064794044 |
DIAPH1
|
Health Risk |
Pathogenic |
— |
| RS1064794045 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS1064794047 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1064794048 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1064794050 |
IGF2
|
Health Risk |
Pathogenic |
Silver-Russell syndrome 1, Silver-Russell syndrome 1 |
| RS1064794051 |
NSD1
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Sotos syndrome |
| RS1064794053 |
ALDH7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1064794055 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064794057 |
BCAP31
|
Health Risk |
Pathogenic |
Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome, Thyroid cancer |
| RS1064794058 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, COL1A2-related disorder |
| RS1064794059 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064794060 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064794062 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS1064794063 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1064794064 |
FZD4
|
Health Risk |
Pathogenic |
— |
| RS1064794065 |
AR
|
Health Risk |
Pathogenic |
— |
| RS1064794066 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1064794068 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS1064794069 |
AR
|
Health Risk |
Pathogenic |
— |